Molecular Characteristics of Early-onset Compared With Late-onset Colorectal Cancer
1 other identifier
observational
11,344
0 countries
N/A
Brief Summary
The distribution rate of microsatellite instability-high (MSI-H) was significantly higher in early-onset colorectal cancer, and early-onset colorectal cancer has a specific mutational profile and relatively high programmed cell death ligand 1(PD-L1) expression, which may be used to guide personalized treatment to better control the disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2003
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2003
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2024
CompletedFirst Submitted
Initial submission to the registry
January 22, 2024
CompletedFirst Posted
Study publicly available on registry
February 2, 2024
CompletedFebruary 2, 2024
February 1, 2024
20 years
January 22, 2024
February 1, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
MSI status
(I) MSI-High (MSI-H) if two or more mononucleotide markers in tumor tissue had size variations of ≥3bp compared to normal tissue; (II) MSI-Low (MSI-L) if a single mononucleotide marker in tumor tissue exhibited a size variation of ≥3bp compared to normal tissue; (III) Microsatellite Stable (MSS) if there were no size variations of ≥3bp in mononucleotide markers in tumor tissue compared to normal tissue.
Through study completion, an average of 1 year
Secondary Outcomes (1)
Copy-number variations (CNVs)
Through study completion, an average of 1 year
Other Outcomes (1)
PD-L1 level
Through study completion, an average of 1 year
Study Arms (2)
Early-onset colorectal cancer
Early-onset colorectal cancer
Late-onset colorectal cancer
Late-onset colorectal cancer
Eligibility Criteria
No.
You may qualify if:
- Men and women aged 18-75 years old;
- Histologically proven colon or rectal adenocarcinoma.
You may not qualify if:
- Patients over 80 years of age;
- Recurrent colorectal cancer;
- Multiple primary tumors.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 22, 2024
First Posted
February 2, 2024
Study Start
January 1, 2003
Primary Completion
December 31, 2022
Study Completion
January 1, 2024
Last Updated
February 2, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share